Provided by Tiger Trade Technology Pte. Ltd.

Avidity Biosciences, Inc.

72.90
+0.08000.11%
Post-market: 72.900.00000.00%17:43 EST
Volume:3.28M
Turnover:239.28M
Market Cap:11.28B
PE:-17.42
High:72.95
Open:72.92
Low:72.79
Close:72.82
52wk High:73.06
52wk Low:21.51
Shares:154.74M
Float Shares:132.00M
Volume Ratio:1.18
T/O Rate:2.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1851
EPS(LYR):-2.8885
ROE:-32.44%
ROA:-20.28%
PB:5.98
PE(LYR):-25.24

Loading ...

Avidity Plans Spin-Off Amid Novartis Acquisition Agreement

TIPRANKS
·
Feb 04

Avidity Biosciences Sets Record Date for Spin-Off Ahead of Novartis Acquisition

Reuters
·
Feb 03

BRIEF-Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off

Reuters
·
Feb 03

Avidity Biosciences Inc - Record Date Set for February 12, 2026 for Spin-off

THOMSON REUTERS
·
Feb 03

Press Release: Avidity Biosciences Announces Expected Record Date for Spin-Off

Dow Jones
·
Feb 03

Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency

GlobeNewswire
·
Feb 02

MGI Tech to Purchase Entire Stakes in Gene Imaging, DNA/RNA Sequencing Companies

MT Newswires Live
·
Feb 02

Avidity Biosciences Sets February Vote on $72-per-Share Novartis Takeover and Cardiology Spin-Off

TIPRANKS
·
Jan 31

Korro Bio Showcases KRRO-121 RNA Editing Program Progress

TIPRANKS
·
Jan 27

Press Release: Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics

Dow Jones
·
Jan 27

Veritas In Silico and SpiroChem Forge AI-Driven Alliance on Next-Generation RNA-Binding Drugs

TIPRANKS
·
Jan 26

Avidity Biosciences Chief Medical Officer Steven George Hughes Reports Disposal of Common Shares

Reuters
·
Jan 24

PYC Therapeutics Advances RNA Drug Pipeline With Key Q4 2025 Clinical Milestones

TIPRANKS
·
Jan 23

Korro to Host Virtual Analyst Day on January 27, 2026

GlobeNewswire
·
Jan 20

FACTBOX-Pharma sector doubles down on AI amid hopes of slashing costs, timelines

Reuters
·
Jan 16

Pipeline Achievement Exceeds Expectations: XTALPI (02228) Secures Tens of Millions in HKD Milestone Payment as AI+RNA Drug RTX-117 Gains Clinical Approvals in China and US

Stock News
·
Jan 14

Converge Bio Secures $25 Million Funding with Backers Including Bessemer Ventures and Executives from Meta, OpenAI, and Wiz

Deep News
·
Jan 13

Novartis eyes more bolt-on acquisitions, CEO says

Reuters
·
Jan 13

ValiRx Strikes RNA Helicase Inhibitor Deal with McGill and IRICoR to Drive Asset-Level Growth

TIPRANKS
·
Jan 09

ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook

GlobeNewswire
·
Jan 08